We are live on ! Find out more
BKYI

BIO-key International
BKYI

10 hedge funds and large institutions have $186K invested in BIO-key International in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $169K → $186K (+$17.3K)

0% more funds holding

Funds holding: 10 → 10 (0)

0% less ownership

Funds ownership: 0.02% → 0.01% (-0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
3
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$7.18K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.26K
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.2K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$9K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$798
3
UBS Group
UBS Group
Switzerland
-$532

BKYI Hedge Fund Activity: Q2 2023 in Review

10 of the 6,381 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2023, worth a combined $186K — up 10% from $169K a quarter earlier.

Fund positioning in BKYI was balanced in Q2 2023: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $7.18K. The largest seller was HRT Financial, exiting entirely with an estimated $9K sold.

  • 10 institutional investors held BIO-key International (BKYI) as of Q2 2023, unchanged from Q1 2023.
  • Funds reported $186K of BIO-key International stock for Q2 2023, up 10% quarter-over-quarter.
  • 3 funds opened new BIO-key International positions in Q2 2023 and 3 closed out, a net change of 0 holders.
  • The largest BIO-key International buyer in Q2 2023 was Citadel Advisors, an estimated $7.18K added.
  • The largest BIO-key International seller in Q2 2023 was HRT Financial, an estimated $9K sold.

Based on aggregated 13F filings for Q2 2023.